GlassScriptPhysician profile
Michelle M Glidden
NPI 1790899680
$7,110.54
in general payments reported to CMS, 2019-2025
35 companies · $1,922 in 2025
The $1,922 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,328 · 2022: $1,239 · 2023: $1,453 · 2024: $1,169 · 2025: $1,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,523 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,523.47 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,433.15 | 2021-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $1,109.01 | 2021-2025 | Verquvo, Lagevrio, Capvaxive |
| Novo Nordisk INC | $627.70 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $615.90 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $357.12 | 2021-2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $322.12 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $255.22 | 2021-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $245.61 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $221.31 | 2021-2025 | Farxiga |
| Bardy Diagnostics, INC. | $177.94 | 2021 | |
| Irhythm Technologies, INC. | $168.69 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $157.04 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $142.18 | 2023-2025 | |
| Esperion Therapeutics, INC. | $128.55 | 2022-2025 | Nexletol |
| Amgen INC. | $114.70 | 2021-2025 | Repatha |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $89.62 | 2022-2024 | Aveir |
| Medtronic, INC. | $86.34 | 2022-2025 | Venaseal |
| Cvrx, INC. | $84.45 | 2023 | Barostim Neo System |
| Heartflow, INC. | $82.43 | 2022-2024 | Ffrct |
| Actelion Pharmaceuticals US, INC. | $80.36 | 2025 | Opsumit, Uptravi |
| Impulse Dynamics (USA) INC. | $62.80 | 2022 | |
| Amarin Pharma, INC. | $61.35 | 2021-2023 | |
| Baxter Healthcare | $55.13 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Lilly USA, LLC | $53.89 | 2025 | Zepbound, Mounjaro |
| Kiniksa Pharmaceuticals International, Plc | $51.64 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $49.63 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $47.83 | 2021-2022 | |
| Watermark Medical, INC. | $41.72 | 2024 | |
| Azurity Pharmaceuticals, INC. | $39.20 | 2024 | Edarbyclor, Horizant |
| Bridgebio Pharma, INC. | $32.37 | 2025 | Attruby |
| Inspire Medical Systems, INC. | $32.10 | 2025 | Inspire |
| Philips North America LLC | $23.62 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Angiodynamics, INC. | $22.06 | 2024 | Auryon Laser System 100-120 Vac |
| Noven Therapeutics, LLC | $20.21 | 2024 | Xelstrym, Secuado |
| Biotronik INC. | $17.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Glidden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.